Doctor profile · Federal record
Dr. JOHN ALLAN, M.D.
Hematology & Oncology Physician (CMS: MEDICAL ONCOLOGY) · Student in an Organized Health Care Education/Training Program · NEW YORK, NY
- NPI 1144462441
- Accepts Medicare
- MIPS 93.4 / 100 · 2023
- 17 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
520 E 70TH ST, STARR PAVILION 341
NEW YORK, NY 100219800
(646) 962-2064
fax (646) 962-1605 - Mailing address
-
575 LEXINGTON AVE
NEW YORK, NY 100226102
Credentials & registration
- NPI registered
- April 2009 — 17 yrs on file
- Profile last updated
- April 17, 2015
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- New York #264134
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1144462441. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,255
Distinct HCPCS
9
Medicare allowed
$163,416
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 422 | 208 | $111 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 329 | 72 | $136 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 286 | 79 | $162 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 56 | 40 | $75 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 46 | 29 | $90 | |
99238 |
Hospital discharge day management, 30 minutes or less | 45 | 38 | $92 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 25 | 25 | $207 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 25 | 21 | $197 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 21 | 21 | $153 |
In context: peer comparison
Among 103 peers in this city , average services per provider: 411. This provider delivers 3.1× the peer median.Open Payments
Industry payments received
All-time total
$51,983
Transactions
64
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 31 | $16,884.02 | |
| BeiGene USA, Inc. | 13 | $12,145.09 | |
| AstraZeneca Pharmaceuticals LP | 2 | $5,800.00 | |
| Merck Sharp & Dohme LLC | 2 | $4,880.00 | |
| Eli Lilly and Company | 2 | $4,400.00 | |
| Adaptive Biotechnologies Corporation | 7 | $4,294.45 | |
| Janssen Global Services, LLC | 3 | $3,183.86 | |
| PFIZER INC. | 1 | $148.47 | |
| Janssen Scientific Affairs, LLC | 1 | $117.17 | |
| Genmab U.S., Inc. | 1 | $105.35 | |
| Genentech USA, Inc. | 1 | $24.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
212
Patients
0
Total drug cost
$1,809,890
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Brukinsa (Zanubrutinib) | Brand | 50 | 0 | $732,292 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 41 | 0 | $1,517 |
| Imbruvica (Ibrutinib) | Brand | 30 | 0 | $474,439 |
| Venclexta (Venetoclax) | Brand | 26 | 0 | $400,888 |
| Entecavir | Generic | 15 | 0 | $6,502 |
| Gabapentin | Generic | 13 | 0 | $61 |
| Prednisone | Generic | 13 | 0 | $18 |
| Amlodipine Besylate | Generic | 12 | 0 | $94 |
| Calquence (Acalabrutinib Maleate) | Brand | 12 | 0 | $194,078 |